CR20160585A - FORMULATED RECEPTORS POLIPEPTIDES AND RELATED METHODS - Google Patents

FORMULATED RECEPTORS POLIPEPTIDES AND RELATED METHODS

Info

Publication number
CR20160585A
CR20160585A CR20160585A CR20160585A CR20160585A CR 20160585 A CR20160585 A CR 20160585A CR 20160585 A CR20160585 A CR 20160585A CR 20160585 A CR20160585 A CR 20160585A CR 20160585 A CR20160585 A CR 20160585A
Authority
CR
Costa Rica
Prior art keywords
related methods
polipeptides
receptors
formulated
disclosed
Prior art date
Application number
CR20160585A
Other languages
Spanish (es)
Inventor
Christopher Michael Haqq
Ramil Latypov
Original Assignee
Santa María Biotherapeutics Inc
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santa María Biotherapeutics Inc, Amgen Inc filed Critical Santa María Biotherapeutics Inc
Priority claimed from PCT/US2015/035818 external-priority patent/WO2015192127A2/en
Publication of CR20160585A publication Critical patent/CR20160585A/en

Links

Abstract

Se revela en la presente una composición a base de un receptor de activina IIB y métodos de uso relacionados, por ejemplo, para tratar tumores sólidos. También se revelan métodos de preparación del compuesto y la formulación.A composition based on an activin IIB receptor and related methods of use, for example, for treating solid tumors is disclosed herein. Methods of preparation of the compound and formulation are also disclosed.

CR20160585A 2014-06-13 2015-06-15 FORMULATED RECEPTORS POLIPEPTIDES AND RELATED METHODS CR20160585A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462012104P 2014-06-13 2014-06-13
US201462047995P 2014-09-09 2014-09-09
US201462058789P 2014-10-02 2014-10-02
PCT/US2015/035818 WO2015192127A2 (en) 2014-06-13 2015-06-15 Formulated receptor polypeptides and related methods

Publications (1)

Publication Number Publication Date
CR20160585A true CR20160585A (en) 2017-04-20

Family

ID=59676863

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160585A CR20160585A (en) 2014-06-13 2015-06-15 FORMULATED RECEPTORS POLIPEPTIDES AND RELATED METHODS

Country Status (1)

Country Link
CR (1) CR20160585A (en)

Similar Documents

Publication Publication Date Title
PH12016502479A1 (en) Formulated receptor polypeptides and related methods
CO2020016619A2 (en) Bispecific anti-pvrig / anti-tigit antibodies and methods of use
ECSP18094857A (en) GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
CL2017001289A1 (en) Fused bicyclic compounds, their compositions and their use for the treatment of diseases related to the modulation of the x-farnesoid receptor (fxr).
CO2018008761A2 (en) Maitansinoid derivatives, conjugates of the same methods of use
ECSP17016797A (en) INDAZOLES SUBSTITUTED WITH BENZYL AS BUB1 INHIBITORS
ECSP17063327A (en) ANTIDLL3 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
CR20160500A (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
CL2016003422A1 (en) Lysine specific demethylase-1 inhibitors
EA201692219A1 (en) METHODS OF OBTAINING ANTI-VIRUS COMPOUNDS
EA201791563A1 (en) SUBSTITUTED NUCLEOSIDE DERIVATIVES, USEFUL AS AN AGENT AGAINST CANCER
CL2016003423A1 (en) Lysine specific demethylase-1 inhibitors
AR101905A1 (en) BICYCLIC COMPOUNDS
EA201790395A1 (en) AMINOTRIAZIN DERIVATIVES SUITABLE FOR USING AS TANK-BINDING KINASE INHIBITORS
CL2018001481A1 (en) New anti-claudin antibodies and their methods of use
EA201791117A1 (en) PARTIAL AGONISTS INSULIN RECEPTOR
EA201791304A1 (en) IZOHINOLINA DERIVATIVES FOR HIV TREATMENT
PE20201286A1 (en) GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES OF THIS
CL2016001973A1 (en) Nucleoside derivatives substituted with 4'-difluoromethyl as inhibitors of influenza arn replication.
GT201700231A (en) AZABENZIMIDAZOLES AND ITS USE AS AMPA RECEIVER MODULATORS
CL2016002008A1 (en) Process for the elaboration of derivatives of pyrimidin sulfamide.
ECSP17031725A (en) ANTI-CLONE ANITIGEN CHEMERIC RECEPTORS AND METHODS OF USE
CR20160374A (en) CYCLOPENTANES REPLACED IN 1,2 AS AN OGREXINE RECEIVER ANTAGONISTS
CL2017000506A1 (en) New anti-mfi2 antibodies and methods of use
CL2016003074A1 (en) Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer.